CCJ Stock Recent News
CCJ LATEST HEADLINES
CNBC's Pippa Stevens joins 'Power Lunch' to discuss the Senate's uranium import ban, which the president is expected to sign soon.
Uranium specialist Cameco (NYSE: CCJ ) has struggled in recent sessions as investors digested its latest financial results. While the print was somewhat downcast, the market appears to be ignoring the broader positive backdrop.
Uranium miner Cameco Corp's chief executive said on Tuesday projected demand from data centers powering technology like generative AI will likely be a boost for nuclear energy.
Cameco Corporation (NYSE:CCJ ) Q1 2024 Earnings Conference Call April 30, 2024 8:00 AM ET Company Participants Rachelle Girard - VP-IR Tim Gitzel - President & CEO Heidi Shockey - SVP & Deputy CFO Grant Isaac - EVP & CFO Sean Quinn - SVP, Chief Legal Officer & Corporate Secretary Dominic Kieran - Global Managing Director of Cameco U.K. Ltd Conference Call Participants Neil Mehta - Goldman Sachs Ralph Profiti - Eight Capital Gordon Johnson - GLJ Research Andrew Wong - RBC Capital Markets Brian MacArthur - Raymond James Orest Wowkodaw - Scotiabank Lawson Winder - Bank of America Securities Greg Barnes - TD Securities Operator Thank you for standing by. This is the conference operator.
In the most recent trading session, Cameco (CCJ) closed at $49.16, indicating a +0.82% shift from the previous trading day.
Cameco's (CCJ) first-quarter results are likely to reflect gains from higher sales volumes and average realized prices as well as contribution from the Westinghouse acquisition.
Cameco (CCJ) concluded the recent trading session at $48.17, signifying a -0.5% move from its prior day's close.
Uranium Energy's stock is up 150% over the past year. The company has a large stockpile of uranium for which it paid historically low prices.
Cameco (CCJ) concluded the recent trading session at $49.59, signifying a -1.74% move from its prior day's close.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.